Chk1 inhibitors

Date 18 March 2017
Event ESMO Symposium on Signalling Pathways in Cancer 2017
Session Development routes for other DDR agents
Topics Biomarkers
Pharmacology
Cancer Immunology and Immunotherapy
Presenter Udai Banerji
Authors U. Banerji
  • The Institute of Cancer Research, SM2 5NG - Sutton/GB